BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析

◆英語タイトル:BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81785FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

BioGaia AB (BIOG B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BioGaia AB (BioGaia) is a biopharmaceutical company, which develops, markets and sells probiotic products. The company sells its probiotic food supplements and oral health products in various dosage forms including drops, lozenges, tablets, chewable tablets, oral rehydration salts (ORS), straws and infant formulas. The company’s major product areas include baby and child gut health, adult gut health, probiotic gastrointestinal health, oral health and bone health. BioGaia’s products are based on various strains of Lactobacillus reuteri, its patented lactic acid bacterium. Its products improve the digestive and oral health of children and adults and controls digestive problems such as colic, regurgitation, diarrhoea and constipation. The company’ sells its products through distributors in the Americas, Europe and Asia-Pacific. BioGaia is headquartered in Stockholm, Sweden.

BioGaia AB Key Recent Developments

Feb 12,2021: MetaboGen has reached a new crucial milestone in its development of novel probiotic products
Feb 04,2021: BioGaia announces year-end report 2020
Oct 23,2020: BioGaia: Interim management statement January – September 2020
Oct 12,2020: BioGaia: Reduced sales due to covid-19
Aug 13,2020: BioGaia: Interim Report January – June 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
BioGaia AB – Key Facts
BioGaia AB – Key Employees
BioGaia AB – Key Employee Biographies
BioGaia AB – Major Products and Services
BioGaia AB – History
BioGaia AB – Company Statement
BioGaia AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioGaia AB – Business Description
Business Segment: Adult Health
Overview
Performance
Business Segment: Other
Overview
Performance
Business Segment: Paediatrics
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: EMEA
Performance
R&D Overview
BioGaia AB – Corporate Strategy
BioGaia AB – SWOT Analysis
SWOT Analysis – Overview
BioGaia AB – Strengths
BioGaia AB – Weaknesses
BioGaia AB – Opportunities
BioGaia AB – Threats
BioGaia AB – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioGaia AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 12, 2021: MetaboGen has reached a new crucial milestone in its development of novel probiotic products
Feb 04, 2021: BioGaia announces year-end report 2020
Oct 23, 2020: BioGaia: Interim management statement January – September 2020
Oct 12, 2020: BioGaia: Reduced sales due to covid-19
Aug 13, 2020: BioGaia: Interim Report January – June 2020
May 07, 2020: BioGaia Interim Management Statement 1 January – 31 March 2020
Mar 30, 2020: BioGaia update concerning COVID-19 pandemic
Feb 06, 2020: BioGaia – Year-end report 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
BioGaia AB, Key Facts
BioGaia AB, Key Employees
BioGaia AB, Key Employee Biographies
BioGaia AB, Major Products and Services
BioGaia AB, History
BioGaia AB, Other Locations
BioGaia AB, Subsidiaries
BioGaia AB, Key Competitors
BioGaia AB, Ratios based on current share price
BioGaia AB, Annual Ratios
BioGaia AB, Annual Ratios (Cont...1)
BioGaia AB, Annual Ratios (Cont...2)
BioGaia AB, Interim Ratios
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
BioGaia AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
BioGaia AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Empresa Electricidad del Peru SA (ELECPBC1):企業の財務・戦略的SWOT分析
    Empresa Electricidad del Peru SA (ELECPBC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Interconexion Electrica SA ESP (ISA):企業の財務・戦略的SWOT分析
    Interconexion Electrica SA ESP (ISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Flex Ltd (FLEX)-エネルギー分野:企業M&A・提携分析
    Summary Flex Ltd (Flex) formerly Flextronics International Ltd is a provider of technology solutions. It designs, manufactures and provides supply chain services to original equipment manufacturers. The company’s major solutions include disposables, drug delivery, diagnostics devices, automotive ele …
  • OBI Pharma Inc (4174):企業の財務・戦略的SWOT分析
    Summary OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a …
  • Sysmex Corp (6869):製薬・医療:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Forward Industries, Inc. (FORD):企業の財務・戦略的SWOT分析
    Forward Industries, Inc. (FORD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Accu-Break Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • PT Sinar Mas Multiartha Tbk (SMMA):企業の財務・戦略的SWOT分析
    PT Sinar Mas Multiartha Tbk (SMMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Saia Inc (SAIA):企業の財務・戦略的SWOT分析
    Saia Inc (SAIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Eastman Chemical Co (EMN):企業の財務・戦略的SWOT分析
    Eastman Chemical Co (EMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • American CryoStem Corp (CRYO):企業の財務・戦略的SWOT分析
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Welspun Corp Ltd:企業の戦略・SWOT・財務情報
    Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. It offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and AL …
  • Merck & Co Inc (MRK):医療機器:M&Aディール及び事業提携情報
    Summary Merck & Co Inc (Merck) is a biopharmaceutical company that focuses on the discovery, development, manufacture and commercialization of prescription medicines, biologic therapies, vaccines and animal health products. It offers prescription products for treating cardiovascular, cancer, immune …
  • Kalle GmbH:企業の戦略的SWOT分析
    Kalle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Ikkuma Resources Corp (IKM):石油・ガス:M&Aディール及び事業提携情報
    Summary Ikkuma Resources Corp (Ikkuma), formerly PanTerra Resource Corp is an oil and gas exploration and development company that operates conventional and unconventional projects. The company conducts drilling operations in Foothills region of Alberta and British Columbia, Canada. It also gathers …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Promaxo Inc:医療機器:M&Aディール及び事業提携情報
    Summary Promaxo Inc (Promaxo) is a medical device company with focus on the development of portable MRI and other technology. The company develops and commercializes office-based, portable magnetic resonance imaging (MRI) devices that possess cellular spatial resolution, besides targeted biopsy and …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務情報
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務情報
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆